Interferon Alfa-2b Combined with Cytarabine versus Interferon Alone in Chronic Myelogenous Leukemia-Reference-Cited by-同舟云学术

Interferon Alfa-2b Combined with Cytarabine versus Interferon Alone in Chronic Myelogenous Leukemia

Published:1997-07-24 Issue:4 Volume:337 Page:223-229
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Guilhot François,Chastang Claude,Michallet Mauricette,Guerci Agnès,Harousseau Jean-Luc,Maloisel Frédéric,Bouabdallah Réda,Guyotat Denis,Cheron Nathalie,Nicolini Franck,Abgrall Jean-François,Tanzer Joseph,Navarro Maurice,Bordessoule Dominique,Morice Patrick,Ifrah Norbert,Rochant Henri,Vilque Jean-Pierre,Delain Martine,Bauters Francis,Guilhot Joëlle

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJM199707243370402

Cited by 493 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical efficacy and safety of first‐line nilotinib or imatinib therapy in patients with chronic myeloid leukemia—Nationwide real life data;Cancer Medicine;2024-09

2. Immune modulation in chronic myeloid leukaemia patients treated with nilotinib and interferon‐alpha;British Journal of Haematology;2023-07-22

3. Key principles of drug therapy in patients with chronic myeloid leukemia;FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology;2023-07-20

4. Leucémie myéloïde chronique : vingt ans d’analyses ciblées sur l’imatinib;Bulletin de l'Académie Nationale de Médecine;2023-06

5. Cytarabine induces cachexia with lipid malabsorption via zippering the junctions of lacteal in murine small intestine;Journal of Lipid Research;2023-06